JP2012500807A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012500807A5 JP2012500807A5 JP2011524124A JP2011524124A JP2012500807A5 JP 2012500807 A5 JP2012500807 A5 JP 2012500807A5 JP 2011524124 A JP2011524124 A JP 2011524124A JP 2011524124 A JP2011524124 A JP 2011524124A JP 2012500807 A5 JP2012500807 A5 JP 2012500807A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- treatment
- composition according
- prevention
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 238000011282 treatment Methods 0.000 claims 6
- 230000002265 prevention Effects 0.000 claims 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 2
- 206010070901 Diabetic dyslipidaemia Diseases 0.000 claims 1
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 239000008186 active pharmaceutical agent Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 229940088679 drug related substance Drugs 0.000 claims 1
- 230000003818 metabolic dysfunction Effects 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ATA1315/2008 | 2008-08-25 | ||
| AT13152008 | 2008-08-25 | ||
| PCT/AT2008/000458 WO2009076693A1 (en) | 2007-12-19 | 2008-12-17 | Octahydroquinoli zines for antidiabetic treatment |
| WOPCT/AT2008/000458 | 2008-12-17 | ||
| PCT/AT2009/000244 WO2010022412A1 (en) | 2008-08-25 | 2009-06-19 | Octahydroquinolizines for antidiabetic treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012500807A JP2012500807A (ja) | 2012-01-12 |
| JP2012500807A5 true JP2012500807A5 (enExample) | 2012-08-02 |
Family
ID=41720682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011524124A Pending JP2012500807A (ja) | 2008-08-25 | 2009-06-19 | 抗糖尿病治療用オクタヒドロキノリジン |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20110160238A1 (enExample) |
| EP (1) | EP2315766A1 (enExample) |
| JP (1) | JP2012500807A (enExample) |
| WO (1) | WO2010022412A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250012601A (ko) * | 2022-05-19 | 2025-01-24 | 인슐렛 코포레이션 | 약물 전달 디바이스들에서의 포도당 예측 모델들의 전환 및 맞춤화 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7538110B2 (en) * | 2005-10-27 | 2009-05-26 | Adolor Corporation | Opioid antagonists |
| NZ585307A (en) * | 2007-12-19 | 2011-11-25 | 55Pharma Drug Discovery & Dev Ag | Octahydroquinolizines for antidiabetic treatment |
-
2009
- 2009-06-19 WO PCT/AT2009/000244 patent/WO2010022412A1/en not_active Ceased
- 2009-06-19 JP JP2011524124A patent/JP2012500807A/ja active Pending
- 2009-06-19 EP EP09775545A patent/EP2315766A1/en not_active Withdrawn
- 2009-06-29 US US13/060,741 patent/US20110160238A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013525444A5 (enExample) | ||
| UA98962C2 (ru) | Аналоги тиреоидного гормона, фармацевтическая композиция, которая их содержит, способ лечения с их использованием, их применение и способ получения | |
| CL2008000198A1 (es) | Compuestos derivados de azacicloalcanos, inhibidores de estearoil-coenzima a delta-9; composicion farmaceutica; y uso para el tratamiento de enfermedades tales como diabetes tipo 2, trastorno de lipidos, obesidad y aterosclerosis. | |
| MX2015001500A (es) | Compuestos antidiabeticos triciclicos. | |
| JP2009530399A5 (enExample) | ||
| WO2008040548A3 (en) | Treatment for non-alcoholic-steatohepatitis | |
| JP2011527332A5 (enExample) | ||
| CL2008001126A1 (es) | Compuestos derivados de pirimidinona condensada con heterociclos; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como diabetes, sindrome metabolico y obesidad. | |
| HRP20161103T1 (hr) | Kemijski spojevi | |
| JP2013509429A5 (enExample) | ||
| JP2014515013A5 (enExample) | ||
| JP2008007519A5 (enExample) | ||
| JP2010519260A5 (enExample) | ||
| JP2010514831A5 (enExample) | ||
| JP2009545527A5 (enExample) | ||
| JP2013532687A5 (enExample) | ||
| JP2011527299A5 (enExample) | ||
| WO2014195966A3 (en) | Amorphous form of canagliflozin and process for preparing thereof | |
| JP2012523395A5 (enExample) | ||
| JP2007302689A5 (enExample) | ||
| WO2008098985A3 (en) | Pharmaceutical composition for the treatment of il-8 mediated diseases | |
| JP2014510741A5 (enExample) | ||
| JP2011046708A5 (enExample) | ||
| JP2015514781A5 (enExample) | ||
| JP2015513544A5 (enExample) |